BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3947397)

  • 41. Affinity of muscarinic receptor antagonists for three putative muscarinic receptor binding sites.
    Delmendo RE; Michel AD; Whiting RL
    Br J Pharmacol; 1989 Feb; 96(2):457-64. PubMed ID: 2924085
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Muscarinic cholinergic receptor subtypes in the human brain. II. Quantitative autoradiographic studies.
    Cortés R; Probst A; Tobler HJ; Palacios JM
    Brain Res; 1986 Jan; 362(2):239-53. PubMed ID: 3753655
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Conversion of N-(2-chloroethyl)-4-piperidinyl diphenylacetate (4-DAMP mustard) to an aziridinium ion and its interaction with muscarinic receptors in various tissues.
    Thomas EA; Hsu HH; Griffin MT; Hunter AL; Luong T; Ehlert FJ
    Mol Pharmacol; 1992 Apr; 41(4):718-26. PubMed ID: 1569923
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Muscarinic receptor characteristics and regulation in rat cerebral cortex: changes during development, aging and the oestrous cycle.
    van Huizen F; March D; Cynader MS; Shaw C
    Eur J Neurosci; 1994 Feb; 6(2):237-43. PubMed ID: 8167845
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Muscarinic receptors in pancreatic islets of the rat. Demonstration and dependence on long-term glucose environment.
    Grill V; Ostenson CG
    Biochim Biophys Acta; 1983 Mar; 756(2):159-62. PubMed ID: 6338932
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Muscarinic activity of McN-A-343 and its value in muscarinic receptor classification.
    Eglen RM; Kenny BA; Michel AD; Whiting RL
    Br J Pharmacol; 1987 Apr; 90(4):693-700. PubMed ID: 2437988
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Muscarinic acetylcholine receptors in chick heart: influence of heat and N-ethylmaleimide on receptor conformations and interactions with guanine nucleotide-dependent regulatory proteins.
    Aronstam RS; Kirby ML; Smith MD
    Neurosci Lett; 1985 Mar; 54(2-3):289-94. PubMed ID: 3838808
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of piracetam administration on 3H-N-methylscopolamine binding in cerebral cortex of young and old rats.
    Viana GS; Marinho MM; Sousa FC
    Life Sci; 1992; 50(13):971-7. PubMed ID: 1548981
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Halothane attenuation of muscarinic inhibition of adenylate cyclase in rat heart.
    Narayanan TK; Confer RA; Dennison RL; Anthony BL; Aronstam RS
    Biochem Pharmacol; 1988 Apr; 37(7):1219-23. PubMed ID: 3128298
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Muscarinic cholinergic receptor subtypes in the rat brain. I. Quantitative autoradiographic studies.
    Cortés R; Palacios JM
    Brain Res; 1986 Jan; 362(2):227-38. PubMed ID: 3942874
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of oxidative stress on (3H)N-methylscopolamine binding and production of thiobarbituric acid reactive substances in rat cerebral cortex membranes.
    Kvaltínová Z; Juránek I; Machová J; Stolc S
    Gen Physiol Biophys; 1993 Apr; 12(2):155-61. PubMed ID: 8405918
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115). Selective loss with subculturing of the low-affinity agonist site mediating cyclic GMP formation.
    McKinney M; Stenstrom S; Richelson E
    Mol Pharmacol; 1984 Sep; 26(2):156-63. PubMed ID: 6148690
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Muscarinic receptor heterogeneity in rat central nervous system. I. Binding of four selective antagonists to three muscarinic receptor subclasses: a comparison with M2 cardiac muscarinic receptors of the C type.
    Waelbroeck M; Gillard M; Robberecht P; Christophe J
    Mol Pharmacol; 1987 Jul; 32(1):91-9. PubMed ID: 3600616
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interaction of the neuromuscular blocking drug atracurium with muscarinic acetylcholine receptors.
    Musílková J; Starshinova LA; Shelkovnikov SA; Tucek S
    Physiol Res; 1991; 40(3):293-304. PubMed ID: 1751476
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Circadian rhythm in muscarinic receptor subtypes in rat forebrain.
    Marquez E; Pavia J; Laukonnen S; Martos F; Gomez A; Rius F; Sanchez de la Cuesta F
    Chronobiol Int; 1990; 7(4):277-82. PubMed ID: 2085868
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relationship between muscarinic receptor occupancy and response in rat parotid acinar cells.
    Dai Y; Baum BJ
    Am J Physiol; 1993 Dec; 265(6 Pt 1):G1122-7. PubMed ID: 8279563
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antimuscarinic effects of chloroquine in rat pancreatic acini.
    Habara Y; Williams JA; Hootman SR
    Biochem Biophys Res Commun; 1986 Jun; 137(2):664-9. PubMed ID: 2425800
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of serotonergic denervation on the density and plasticity of brain muscarinic receptors in the rat.
    Alonso R; Soubrie P
    Synapse; 1991 May; 8(1):30-7. PubMed ID: 1714634
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Heterogeneity of binding of muscarinic receptor antagonists in rat brain homogenates.
    Lee JH; el-Fakahany EE
    J Pharmacol Exp Ther; 1985 Jun; 233(3):707-14. PubMed ID: 3839264
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influence of pH on the binding of scopolamine and N-methylscopolamine to muscarinic receptors in the corpus striatum and heart of rats.
    Ehlert FJ; Delen FM
    Mol Pharmacol; 1990 Jul; 38(1):143-7. PubMed ID: 2370852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.